1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017 年版). 中华肝脏病杂志, 2017, 25(12): 886-895.
|
3. |
Wen T, Jin C, Facciorusso A, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr, 2018, 7(5): 353-371.
|
4. |
European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol, 2018, 69(1): 182-236.
|
5. |
Shi M, Zhang CQ, Zhang YQ, et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg, 2004, 28(4): 376-381.
|
6. |
Shimada K, Sakamoto Y, Esaki M, et al. Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg, 2008, 195(6): 775-781.
|
7. |
Lee W, Han HS, Ahn S, et al. Correlation between resection margin and disease recurrence with a restricted cubic spline model in patients with resected hepatocellular carcinoma. Dig Surg, 2018, 35(6): 520-531.
|
8. |
Hu W, Pang X, Guo W, et al. Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma. Int J Clin Exp Pathol, 2015, 8(3): 3404-3409.
|
9. |
Hirokawa F, Hayashi M, Miyamoto Y, et al. Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res, 2014, 44(8): 846-853.
|
10. |
Itamoto T, Nakahara H, Tashiro H, et al. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis. Am J Surg, 2005, 189(2): 167-172.
|
11. |
Nanashima A, Tobinaga S, Kunizaki M, et al. Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy. J Surg Oncol, 2010, 101(7): 557-563.
|
12. |
Dong S, Wang Z, Wu L, et al. Effect of surgical margin in R0 hepatectomy on recurrence-free survival of patients with solitary hepatocellular carcinomas without macroscopic vascular invasion. Medicine (Baltimore), 2016, 95(44): e5251.
|
13. |
Zheng J, Seier K, Gonen M, et al. Utility of serum inflammatory markers for predicting microvascular invasion and survival for patients with hepatocellular carcinoma. Ann Surg Oncol, 2017, 24(12): 3706-3714.
|
14. |
Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol, 2016, 64(4): 773-780.
|
15. |
Sasaki K, Matsuda M, Ohkura Y, et al. Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients. Hepatol Res, 2013, 43(12): 1295-1303.
|
16. |
Shen J, Wen J, Li C, et al. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis. BMC Cancer, 2018, 18(1): 278.
|
17. |
Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg, 2000, 231(4): 544-551.
|
18. |
Sakon M, Ogawa H, Fujita M, et al. Hepatic resection for hepatocellular carcinoma based on tumor hemodynamics. Hepatol Res, 2013, 43(2): 155-164.
|
19. |
Zhou XP, Quan ZW, Cong WM, et al. Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer. World J Gastroenterol, 2007, 13(33): 4498-4503.
|
20. |
Yu W, Wang W, Rong W, et al. Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (J Am Coll Surg, 2014, 218(3): 381-392.
|
21. |
Field WBS, Rostas JW, Philps P, et al. Wide versus narrow margins after partial hepatectomy for hepatocellular carcinoma: Balancing recurrence risk and liver function. Am J Surg, 2017, 214(2): 273-277.
|
22. |
Lee JW, Lee YJ, Park KM, et al. Anatomical resection but not surgical margin width influence survival following resection for HCC, a propensity score analysis. World J Surg, 2016, 40(6): 1429-1439.
|
23. |
Lee KT, Wang SN, Su RW, et al. Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma? J Formos Med Assoc, 2012, 111(3): 160-170.
|
24. |
徐立, 石明, 张亚奇, 等. 肝细胞癌手术切缘对患者术后复发与生存的影响. 中华肿瘤杂志, 2006, 28(1): 47-49.
|
25. |
Zhong FP, Zhang YJ, Liu Y, et al. Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore), 2017, 96(37): e8043.
|
26. |
Kingham TP, Correa-Gallego C, D’Angelica MI, et al. Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4 152 resections for malignancy. J Am Coll Surg, 2015, 220(4): 471-479.
|
27. |
Gold JS, Are C, Kornprat P, et al. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg, 2008, 247(1): 109-117.
|